Quantum BioPharma Ltd. (QNTM NASDAQ) stock market data APIs
$19.41
0.95(4.9%)
as of July 1, 2025
Try our APIs with
free plan!
Quantum BioPharma Ltd. Financial Data Overview
Price chart is built with
Anychart
Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is headquartered in Toronto, Canada.
Prev. Close
19.41
Open
20.3586
High
20.834
Low
18.9506
52 wk Range
2.7-38.25
Market Cap
57 249 K
Shares Outstanding
2 908 K
EPS
-2.3311
Beta
1.466
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Quantum BioPharma Ltd. data using free add-ons & libraries
Get Quantum BioPharma Ltd. Fundamental Data
Quantum BioPharma Ltd. Fundamental data includes:
- Net Revenue:
- EBITDA: -16 776 207
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-12
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Quantum BioPharma Ltd. News
New
Quantum BioPharma announces private placement
* Quantum BioPharma (NASDAQ:QNTM [https://seekingalpha.com/symbol/QNTM]) said on Friday that it is completing a non-brokered private placement [https://seekingalpha.com/pr/20150935-quantum-biopharma...
Quantum BioPharma Announces Private Placement
TORONTO, June 27, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a p...
Unbuzzd Wellness engages firms to raise up to $5 million
TORONTO - Unbuzzd Wellness Inc., the company behind a beverage designed to accelerate alcohol metabolism, has engaged marketing firm MZ Digital and crowdfunding platform Dealmaker to raise up to $5 mi...
Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering
TORONTO, June 26, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), a biopharmaceutical company dedicated to building a portfolio of i...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
